State Board of Administration of Florida Retirement System Raises Position in Agilent Technologies, Inc. $A

State Board of Administration of Florida Retirement System grew its holdings in Agilent Technologies, Inc. (NYSE:A) by 0.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 279,719 shares of the medical research company’s stock after acquiring an additional 800 shares during the period. State Board of Administration of Florida Retirement System’s holdings in Agilent Technologies were worth $33,010,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also modified their holdings of the company. Stone House Investment Management LLC acquired a new position in Agilent Technologies during the 1st quarter worth $30,000. Ransom Advisory Ltd acquired a new stake in Agilent Technologies in the 1st quarter valued at about $32,000. Central Pacific Bank Trust Division purchased a new position in shares of Agilent Technologies in the 2nd quarter valued at about $33,000. Zions Bancorporation National Association UT acquired a new position in shares of Agilent Technologies during the first quarter worth about $38,000. Finally, Costello Asset Management INC purchased a new stake in shares of Agilent Technologies during the first quarter worth approximately $47,000. Hedge funds and other institutional investors own 87.41% of the company’s stock.

Insiders Place Their Bets

In related news, CEO Padraig Mcdonnell sold 911 shares of the stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $143.24, for a total transaction of $130,491.64. Following the completion of the sale, the chief executive officer owned 32,058 shares in the company, valued at $4,591,987.92. This represents a 2.76% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.26% of the stock is currently owned by corporate insiders.

Agilent Technologies Stock Down 0.6%

A opened at $153.48 on Friday. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $160.27. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25. The stock has a market capitalization of $43.51 billion, a P/E ratio of 36.03, a price-to-earnings-growth ratio of 4.67 and a beta of 1.29. The business’s 50-day simple moving average is $142.44 and its 200-day simple moving average is $126.77.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.58 by $0.01. The firm had revenue of $1.86 billion for the quarter, compared to the consensus estimate of $1.83 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The firm’s quarterly revenue was up 9.4% compared to the same quarter last year. During the same quarter last year, the business posted $1.46 EPS. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS. FY 2026 guidance at 5.860-6.000 EPS. Analysts anticipate that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 28th. Investors of record on Tuesday, January 6th will be given a $0.255 dividend. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.25. The ex-dividend date is Tuesday, January 6th. This represents a $1.02 annualized dividend and a yield of 0.7%. Agilent Technologies’s payout ratio is currently 22.32%.

Wall Street Analyst Weigh In

Several research firms have commented on A. TD Cowen boosted their price target on shares of Agilent Technologies from $150.00 to $162.00 and gave the stock a “buy” rating in a report on Tuesday, October 14th. Robert W. Baird boosted their target price on shares of Agilent Technologies from $142.00 to $165.00 and gave the stock an “outperform” rating in a research note on Tuesday, November 25th. Rothschild & Co Redburn started coverage on Agilent Technologies in a report on Wednesday, October 8th. They issued a “buy” rating and a $165.00 target price on the stock. Wall Street Zen raised Agilent Technologies from a “hold” rating to a “buy” rating in a report on Friday, October 3rd. Finally, Evercore ISI increased their price objective on Agilent Technologies from $128.00 to $140.00 and gave the company an “in-line” rating in a report on Tuesday, October 7th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Agilent Technologies presently has an average rating of “Moderate Buy” and a consensus price target of $161.08.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.